|Target:||Quality: Increased research effort in the National Research Priority areas, the national health priority areas, and other priority areas as identified in the NHMRC's Strategic Plan 2003-06.|
The NHMRC grant payments for strategic awards in National Research Priority Areas, the national health priority areas, and other priority areas as identified in the NHMRC's Strategic Plan 2003-06, have increased steadily over the triennium from $19.7 million in 2003-04 to $26.0 million in 2004-05 and $35.3 million in 2005-06.
|Target:||Quality: Compliance with the National Statement on Ethical Conduct in Research Involving Humans by registered Human Research Ethics Committees.|
Of the 230 Human Research Ethics Committees registered with the NHMRC in 2005-06, all were assessed as compliant with the National Statement on Ethical Conduct in Research Involving Humans.
|Target:||Quality: Compliance with the requirements of the Research Involving Human Embryos Act 2002 and the Prohibition of Human Cloning Act 2002.|
|Result:||Target met.||The NHMRC monitored compliance with the Acts through inspections of institutions licensed to conduct research under the Research Involving Human Embryos Act. All institutions were found to be compliant with the two Acts.|
|Target:||Quality: Ministers' satisfaction with the quality, relevance and timeliness of our advice for Australian Government decision making.|
|Result:||Target met.||Ministers were satisfied with the quality, relevance and timeliness of advice provided for Australian Government decision making.|
|Target:||Quality: Production of timely evidence-based advice.|
The NHMRC supported the timely production of evidence-based policy research in accordance with its legislation and Strategic Plan for 2003-06. 17 publications were released during the year under Sections 13 and 14 of the NHMRC Act (see Appendix XV - Guidelines and Publications of the NHMRC's 2005 Annual Report for a list of the publications released).
|Target:||Quality: Provision of opportunity for relevant stakeholders to participate in the development of evidenced-based advice.|
|Result:||Target met.||There is a legislative requirement under the NHMRC Act for the NHMRC to
consult and have consumer representation on the Council and Principal Committees.
Consumer representation is held on the Council, the Health Advisory Committee,
Research Committee, Licensing Committee, Human Genetics Advisory Committee
and the Australian Health Ethics Committee.
In the past 12 months, the NHMRC held public consultations for 9 separate important public health and ethical research issues resulting in more that 480 separate submissions (see Appendix XIV - Meetings, Public Consultations and Public Forums of the NHMRC's 2005 Annual Report).
|Target:||Quality: Timely production of ethics advice.|
The NHMRC continued to issue timely advice to Human Research Ethics Committees (HRECs) and researchers, as needed on ethical issues as they arose. In 2005-06 this was done via the NHMRC web site, through the Winter and Spring 2005 issues of the HREC Bulletins and since February 2006, through the bulletin's replacement, HREC Alert.
|Target:||Quality: Administered budget predictions are met and actual expenses vary less than 0.5% from budgeted expenses.|
|Result:||Target not met.||Administered budget predictions were not met. Actual expenses varied by 2.6% from budgeted expenses. This outcome is a result of the NHMRC funding process where grants announced during the year are paid to institutions over a 3 to 5 year period. Unexpended funds are held to meet future commitments.|
|Target:||Quality: Opportunity for stakeholders to participate in program development.|
The NHMRC provided opportunities for stakeholders to participate in program development through 2 rounds of consultation relating to the revision of Joint NHMRC/AVCC Statement and Guidelines on Research Practice 1997.
An Australia-wide road show was also conducted to enable stakeholders to provide input to the NHMRC's re-engineering of health and medical research for the coming triennium.
Public consultation was undertaken on a number of issues. Full details area contained in Appendix XIV - Meetings, Public Consultations and Public Forums of the NHMRC's 2005 Annual Report.
|Target:||Quality: Development and management of contracts comply with procurement and accountability guidelines.|
|Result:||Target not met.||Contracts and consultancies awarded during 2005-06 were developed and managed in accordance with best practice Commonwealth procurement and funding guidelines.|
|Target:||Quality: Effective implementation of legislative reviews and compliance with legislation.|
During 2005-06, the NHMRC complied with all aspects on the NHMRC Act, the Prohibition of Human Cloning Act 2002 (PHC Act) and the Research Involving Human Embryos Act 2002 (RIHE Act).
Independent reviews of the PHC Act 2002 and RIHE Act 2002 were completed during 2005-06. The reviews (the Lockhart Reviews) are a statutory requirement of both Acts. The reports of the reviews were tabled in both Houses of Parliament and provided to the Council of Australian Governments on 19 December 2005.
In accordance with Section 19(3) of the RIHE Act, the NHMRC tabled biannual reports on the operation of the Act and licences issued under the Act. In 2005-06, reports were tabled for the periods 1 April 2005 to September 2005 and 1 October 2005 to 31 March 2006.
Produced by the Portfolio Strategies Division, Australian Government Department of Health and Ageing.
If you would like to know more or give us your comments contact: email@example.com